Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylp ropionic acid and its pharmaceutical compositions containing the same

Details for Australian Patent Application No. 2004270154 (hide)

Owner Wyeth

Inventors Jain, Ashwinkumar; Ashraf, Muhammad; Benjamin, Eric J.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004270154

PCT Pub. Number WO2005/023254

Priority 60/499,789 03.09.03 US

Filing date 16 August 2004

Wipo publication date 17 March 2005

International Classifications

A61K 31/436 (2006.01)

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07D 498/18 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/023254 Priority application(s): WO2005/023254

3 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004270155-Cyclohexyl prostaglandin analogs as EP4-receptor agonists

2004270150-Combination methods of treating cancer